![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » YM BIOSCIENCES'S CANCER DRUG GETS APPROVAL IN INDIA
YM BIOSCIENCES'S CANCER DRUG GETS APPROVAL IN INDIA
YM BioSciences Inc., a company engaged in the acquisition, development and commercialization of oncology and acute care products, has reported that India's Drug Controller General has granted marketing approval to nimotuzumab, an anti-EGFr monoclonal antibody, for the treatment of head & neck cancer.
BioSpectrum (http://www.biospectrumasia.com/content/210706IND1187.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct